中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
19期
123-124,139
,共3页
夏云%瞿伟%陶珊珊%涂剑宏
夏雲%瞿偉%陶珊珊%塗劍宏
하운%구위%도산산%도검굉
乳腺髓样癌%E-cadherin%Ki-67%临床病理特征
乳腺髓樣癌%E-cadherin%Ki-67%臨床病理特徵
유선수양암%E-cadherin%Ki-67%림상병리특정
Medullary carcinoma of breast%E-cadherin%Ki-67%Clinical pathological features
目的:探讨E-cadherin、Ki-67在乳腺髓样癌中表达及临床病理意义。方法采用免疫组织化学方法检测42例乳腺髓样癌中E-cadherin、Ki-67的表达。结果 E-cadherin和Ki-67蛋白表达阳性率在乳腺髓样癌中表达分别为81%(34/42)和76.2%(32/42)。E-cadherin表达阳性率与淋巴结转移呈显著相关(P<0.05),而与患者年龄、肿瘤大小及是否远处转移无关(P>0.05);Ki-67表达及阳性程度随着病理组织学分级、淋巴结转移而增加。结论 E-cadherin和Ki-67蛋白的表达差异是影响乳腺髓样癌预后的重要原因。
目的:探討E-cadherin、Ki-67在乳腺髓樣癌中錶達及臨床病理意義。方法採用免疫組織化學方法檢測42例乳腺髓樣癌中E-cadherin、Ki-67的錶達。結果 E-cadherin和Ki-67蛋白錶達暘性率在乳腺髓樣癌中錶達分彆為81%(34/42)和76.2%(32/42)。E-cadherin錶達暘性率與淋巴結轉移呈顯著相關(P<0.05),而與患者年齡、腫瘤大小及是否遠處轉移無關(P>0.05);Ki-67錶達及暘性程度隨著病理組織學分級、淋巴結轉移而增加。結論 E-cadherin和Ki-67蛋白的錶達差異是影響乳腺髓樣癌預後的重要原因。
목적:탐토E-cadherin、Ki-67재유선수양암중표체급림상병리의의。방법채용면역조직화학방법검측42례유선수양암중E-cadherin、Ki-67적표체。결과 E-cadherin화Ki-67단백표체양성솔재유선수양암중표체분별위81%(34/42)화76.2%(32/42)。E-cadherin표체양성솔여림파결전이정현저상관(P<0.05),이여환자년령、종류대소급시부원처전이무관(P>0.05);Ki-67표체급양성정도수착병리조직학분급、림파결전이이증가。결론 E-cadherin화Ki-67단백적표체차이시영향유선수양암예후적중요원인。
Objective To explore expression of E-cadherin and Ki-67 protein and clinical Pathological significance in the Medullary Carcinoma of Breast. Methods Using immunohistochemical method to detect the expression of E-cadherin and Ki-67in 42 cases of mammary medullary carcinoma. Results E-cadherin and Ki-67 protein expression positive rate in the medullary carcinoma of breast was 81%(34/42) and 76.2%(32/42).E-cadherin expression positive rate was significantly correlated with lymph node metastases(P < 0.05), and regardless of with age of the patient, tumor size, distant metastasis(P > 0.05).Ki-67 expression rate and positive degree increased with pathology histology classification,lymph node metastasis. Conclusion E-adherin and Ki-67 protein expression difference is the important reasons influence breast medullary carcinoma prognosis.